Abstract
Sabarubicin (MEN 10755) is the progenitor of a third generation of synthetic anthracycline oligosaccharides. Sabarubicin deamino analogues MEN 10959 and MEN 12297 were evaluated for topoisomerase II poisoning, cytotoxic potency and antitumor activity in human xenografts. The new analogues were able to induce DNA cleavage mediated by both DNA topoisomerase IIα and β and a good correlation was found regarding their cytotoxic activity. The two analogues possess also a different spectrum of antitumor activity, compared to sabarubicin.
Keywords: sabarubicin, men 10755, men 10959, men 12297, anthracycline disaccharides, dna topoisomerase
Letters in Drug Design & Discovery
Title: Pharmacological Profile of New Deamino Analogues of Sabarubicin (MEN 10755)
Volume: 2 Issue: 1
Author(s): M. Bigioni, C. Salvatore, A. Cipollone, M. Berettoni, C. A. Maggi and M. Binaschi
Affiliation:
Keywords: sabarubicin, men 10755, men 10959, men 12297, anthracycline disaccharides, dna topoisomerase
Abstract: Sabarubicin (MEN 10755) is the progenitor of a third generation of synthetic anthracycline oligosaccharides. Sabarubicin deamino analogues MEN 10959 and MEN 12297 were evaluated for topoisomerase II poisoning, cytotoxic potency and antitumor activity in human xenografts. The new analogues were able to induce DNA cleavage mediated by both DNA topoisomerase IIα and β and a good correlation was found regarding their cytotoxic activity. The two analogues possess also a different spectrum of antitumor activity, compared to sabarubicin.
Export Options
About this article
Cite this article as:
Bigioni M., Salvatore C., Cipollone A., Berettoni M., Maggi A. C. and Binaschi M., Pharmacological Profile of New Deamino Analogues of Sabarubicin (MEN 10755), Letters in Drug Design & Discovery 2005; 2 (1) . https://dx.doi.org/10.2174/1570180053398307
DOI https://dx.doi.org/10.2174/1570180053398307 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers